- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: Banzel® | CGP-33101 | Inovelon® | RUF-331
rufinamide is an approved drug (EMA (2007), FDA (2008))
Compound class: Synthetic organic
Comment: Rufinamide is a triazole (a heterocyclic compound with molecular formula C2H3N3) derivative anticonvulsant drug.
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
View more information in the IUPHAR Pharmacology Education Project: rufinamide
|Rodent studies show that rufinamide (1μM) significantly slows sodium channel recovery from inactivation in cultured cortical neurons from immature rats and that the drug limits sustained repetitive firing of sodium-dependent action potentials, with an EC50 of 3.8μM .
However, we have been unable to find publicly available bioactivity data for this drug at its proposed human molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target.